Ashwini R. Bhat, MBBS

Ashwini Bhat practices at Kent Hospital in Warwick, Rhode Island, part of Care New England Health System.

Ashwini Bhat's NPI, 1194258020, was assigned on April 7, 2017. Ashwini Bhat holds Rhode Island license MD19770.

Ashwini Bhat's primary practice is Kent Hospital, at 455 Toll Gate Rd, Warwick, RI 02886 in Kent County. The practice phone is (401) 737-7010.

Ashwini Bhat's primary practice is Kent Hospital in Warwick, Rhode Island, part of Care New England Health System. Ashwini Bhat is also affiliated with Brigham and Women's Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Ashwini Bhat to 4 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ashwini Bhat practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Ashwini Bhat's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Ashwini Bhat is licensed in Rhode Island.

CMS data shows 303 Medicare services from Ashwini Bhat across 6 procedure codes in 2024, for 264 Medicare patients. Medicare paid $9,802 for them.

CMS counts 264 Medicare patients who saw Ashwini Bhat in 2024. The largest group is 75 to 84, with 110 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ashwini Bhat's median patient age at 71, with 53% women.

In 2024, Ashwini Bhat wrote 65 Medicare Part D claims for 32 patients. 68% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $13,378 in total drug cost. In 2020, CMS named 93 claims across 6 drugs.

Ashwini Bhat accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 31 general payments to Ashwini Bhat from 9 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $153.